Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,628
Recruiting: 1,398
Ph III recruiting: 152
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 51–100 of 1,443 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01556243	Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer	completed	Phase 2	270	Alliance for Clinical Trials in OncologyOTHER	1	Jun 12, 2026	clinicaltrials
NCT06513364	Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer	completed	Phase 2	40	Beijing Wehand-Bio Pharmaceutical Co., LtdINDUSTRY	1	Jun 9, 2026	clinicaltrials